drugset / Trial / NCT01060111

An Efficacy and Tolerability Study of Topiramate in Participants With Migraine

NCT01060111

Phase 4 Completed 250 enrolled Janssen Korea, Ltd., Korea
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to investigate the adequacy (reasonably good) of topiramate therapy (medicine or medical care given to a participant for a disease or condition) in prevention of migraine (type of severe headache that occurs periodically and is often associated with nausea, vomiting, and constipation or diarrhea) by comparing standard titration (slow increase in drug dosage, guided by patient's responses) therapy to slow titration therapy and slow titration therapy boosted by the concurrent use of propranolol in participants with migraine with or without aura (having to do with the ear) for more than or equal to 2 attacks per month.

Timeline

Start
2006-07
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 80 mg
Subject Topiramate Small molecule 50 mg
Subject Topiramate Small molecule 100 mg

Indications